We are live on ! Find out more
RDUS

Radius Health, Inc.

Delisted

RDUS was delisted on the 12th of August, 2022.

135 hedge funds and large institutions have $348M invested in Radius Health, Inc. in 2021 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 47 increasing their positions, 34 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more call options, than puts

Call options by funds: $4.59M | Put options by funds: $2.8M

38% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 34

0% more funds holding

Funds holding: 135135 (0)

0% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 29

42% less capital invested

Capital invested by funds: $602M → $348M (-$254M)

Holders
135
Holders Change
Holders Change %
0%
% of All Funds
2.08%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
47
Reduced
34
Closed
29
Calls
$4.59M
Puts
$2.8M
Net Calls
+$1.79M
Net Calls Change
-$444K
Name Holding Trade Value Shares
Change
Change in
Stake
BG
1
Bellevue Group
Switzerland
$53.8M
RCMNY
2
Rubric Capital Management (New York)
New York
$48.2M +$48.2M +3,284,305 +89%
Vanguard Group
3
Vanguard Group
Pennsylvania
$32.3M -$1.85K -126 -0%
State Street
4
State Street
Massachusetts
$30.1M +$30M +2,042,656 +88%
BlackRock
5
BlackRock
New York
$24.6M +$492K +33,509 +1%
FCM
6
Farallon Capital Management
California
$14.6M
UBS Group
7
UBS Group
Switzerland
$13M +$25.9M +1,766,933 +1,588%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$11M -$89.5M -6,097,624 -79%
Wellington Management Group
9
Wellington Management Group
Massachusetts
$8.65M -$14.1M -960,836 -43%
Millennium Management
10
Millennium Management
New York
$6.52M +$13.6M +928,986 +6,788%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$6.1M +$1.02M +69,188 +9%
Two Sigma Advisers
12
Two Sigma Advisers
New York
$5.67M +$8.17M +557,100 +213%
TCM
13
Tang Capital Management
California
$5.29M +$11.2M +763,888 New
Hudson Bay Capital Management
14
Hudson Bay Capital Management
Connecticut
$5.19M +$1.83M +125,000 +20%
Jacobs Levy Equity Management
15
Jacobs Levy Equity Management
New Jersey
$4.63M -$1M -68,189 -9%
RP
16
Repertoire Partners
New York
$4.41M +$9.35M +637,464 New
Two Sigma Investments
17
Two Sigma Investments
New York
$4.04M +$6.17M +420,620 +257%
N
18
Nuveen
North Carolina
$3.63M +$3.48M +237,347 +80%
Northern Trust
19
Northern Trust
Illinois
$3.56M -$128K -8,751 -2%
Morgan Stanley
20
Morgan Stanley
New York
$3.46M +$910K +62,013 +14%
Charles Schwab
21
Charles Schwab
California
$2.82M +$476K +32,458 +9%
Goldman Sachs
22
Goldman Sachs
New York
$2.65M -$4.23M -288,025 -43%
Norges Bank
23
Norges Bank
Norway
$2.38M
ECM
24
ExodusPoint Capital Management
New York
$2.31M +$4.48M +305,608 +1,058%
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$2.3M +$1.32M +90,217 +37%

RDUS Hedge Fund Activity: Q4 2021 in Review

135 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Radius Health, Inc. (RDUS) for Q4 2021, worth a combined $348M — down 42% from $602M a quarter earlier.

Fund positioning in RDUS was balanced in Q4 2021: 29 funds opened new positions, 29 closed out, 47 added to existing stakes and 34 trimmed.

The largest buyer was Rubric Capital Management (New York), adding an estimated $48.2M. The largest seller was T. Rowe Price Associates, cutting an estimated $89.5M.

  • 135 institutional investors held Radius Health, Inc. (RDUS) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $348M of Radius Health, Inc. stock for Q4 2021, down 42% quarter-over-quarter.
  • 29 funds opened new Radius Health, Inc. positions in Q4 2021 and 29 closed out, a net change of 0 holders.
  • The largest Radius Health, Inc. buyer in Q4 2021 was Rubric Capital Management (New York), an estimated $48.2M added.
  • The largest Radius Health, Inc. seller in Q4 2021 was T. Rowe Price Associates, an estimated $89.5M sold.

Based on aggregated 13F filings for Q4 2021.